Terms: = Uterine cancer AND MUC16, CA125, CA-125 AND Prognosis
169 results:
1. Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in uterine Sarcoma.
Yang L; Cai Y; Wang Y; Huang Y; Zhang C; Ma H; Zhou JG
Technol Cancer Res Treat; 2024; 23():15330338241245924. PubMed ID: 38613349
[TBL] [Abstract] [Full Text] [Related]
2. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
3. [Postoperative lymph node metastasis status and related factors in patients with early-stage, low-risk endometrial cancer assessed by the Mayo criteria].
Shi XW; Wang DF; Zhang GN; Zhang J
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):736-741. PubMed ID: 38462353
[No Abstract] [Full Text] [Related]
4. Ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment.
Chang TY; Yeh CY; Yang CY; Lin WC; Huang CC; Hung YC
Taiwan J Obstet Gynecol; 2024 Jan; 63(1):90-94. PubMed ID: 38216278
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Factors for uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
6. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
Miller HA; Tran A; LyBarger KS; Frieboes HB
Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
[TBL] [Abstract] [Full Text] [Related]
7. Identifying tumor markers-stratified subtypes (ca-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma.
Zhang Z; Li Y; Wu Y; Bi R; Wu X; Ke G; Zhu J
Int J Biol Markers; 2023 Dec; 38(3-4):223-232. PubMed ID: 37933442
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
9. The relationship between serum ca-125 level and recurrence in surgical stage I endometrial cancer patients.
Wu HH; Chou HT; Tseng JY; Chan IS; Chen YJ
J Chin Med Assoc; 2023 Nov; 86(11):1001-1007. PubMed ID: 37643918
[TBL] [Abstract] [Full Text] [Related]
10. Expression and clinical significance of PD-1 in UCEC and its Impact on tumor.
Xing F; Yang Y; Zheng W
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):168-173. PubMed ID: 37571885
[TBL] [Abstract] [Full Text] [Related]
11. Fortuitously detected primary ovarian carcinoid tumor: A case report.
Choi HY; Pak MG; Park JW
Medicine (Baltimore); 2023 Aug; 102(31):e34391. PubMed ID: 37543794
[TBL] [Abstract] [Full Text] [Related]
12. A nomogram prediction model for the TP53mut subtype in endometrial cancer based on preoperative noninvasive parameters.
Wang W; Li X; Gao Y; Zheng H; Gao M
BMC Cancer; 2023 Aug; 23(1):720. PubMed ID: 37528420
[TBL] [Abstract] [Full Text] [Related]
13. An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China.
Chen S; Lu H; Jiang S; Li M; Weng H; Zhu J; Zhang T; Wang Y; Zhao W; Wu D; Shen Z; Yang Z; Zhou Y
BMC Cancer; 2023 Jul; 23(1):608. PubMed ID: 37391693
[TBL] [Abstract] [Full Text] [Related]
14. [prognosis analysis of radical or modified radical hysterectomy and simple hysterectomy in patients with stage Ⅱ endometrial cancer].
Zhai ZY; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Jun; 58(6):442-450. PubMed ID: 37357603
[No Abstract] [Full Text] [Related]
15. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
[TBL] [Abstract] [Full Text] [Related]
16. The presence of clear cell glands around the ovarian endometrioid cyst has an association with clear cell carcinoma.
Qu J; Yu J; Zhong S; Wang W; Wang Q; Du B
Virchows Arch; 2023 Jun; 482(6):1021-1034. PubMed ID: 36580137
[TBL] [Abstract] [Full Text] [Related]
17. Prediction of high-risk factors for ovarian metastasis in patients with endometrial cancer: A large-sample retrospective case-control study.
Li Q; Zhang X
Int J Gynaecol Obstet; 2023 Apr; 161(1):144-150. PubMed ID: 36453189
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative serum ca125 level and age at diagnosis: An effective prognosis prediction tool for patients with early-stage endometrial cancer.
Sun S; Wei L; Zou L; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Wang W; Zhang F; Hou X; Hu K
Asia Pac J Clin Oncol; 2023 Oct; 19(5):e258-e266. PubMed ID: 36352545
[TBL] [Abstract] [Full Text] [Related]
19. Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer.
Asami Y; Hiranuma K; Takayanagi D; Matsuda M; Shimada Y; Kato MK; Kuno I; Murakami N; Komatsu M; Hamamoto R; Kohno T; Sekizawa A; Matsumoto K; Kato T; Yoshida H; Shiraishi K
Sci Rep; 2022 Nov; 12(1):19004. PubMed ID: 36347927
[TBL] [Abstract] [Full Text] [Related]
20. Changes of T Lymphocyte Subsets in Peripheral Blood of Patients with Intermediate and Advanced Cervical cancer before and after Nimotuzumab Combined with Chemoradiotherapy.
Teng F; Cui G; Qian L; Zhao L
Int Arch Allergy Immunol; 2023; 184(1):85-97. PubMed ID: 36265457
[TBL] [Abstract] [Full Text] [Related]
[Next]